# AMPLIMED CORPORATION

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/amplimed

- Industry: Pharmaceuticals
- Headquarters: Tucson, US
- Website: www.amplimed.com
- Total disclosed funding: $31M
- Latest round: Series D (Mar 3, 2010)
- Investors on record: 6

## About

AMPLIMED CORPORATION is a company focused on developing and providing innovative solutions in the healthcare sector, specifically through its advanced medical technologies and therapeutic products.Founded in 1989 in Tucson, US, AMPLIMED CORPORATION specializes in healthcare solutions. The company has undergone various strategic pivots and has raised a total of USD 1.49 mn across several funding rounds, with the latest being a Series D round involving investors such as Solstice Capital and Valley Ventures. The current company valuation is USD 27.867 mn.AMPLIMED CORPORATION offers a range of healthcare products and services aimed at improving patient outcomes and streamlining medical processes. Its portfolio includes advanced medical devices and therapeutic solutions designed for healthcare providers, ensuring efficient and effective patient care. The company's products are distributed globally, with a focus on major markets in North America, Europe, and Asia.The revenue model of AMPLIMED CORPORATION is primarily based on direct sales through healthcare institutions and partnerships with distributors. Products are priced based on their technological advancements and the specific needs of healthcare providers, allowing for scalability and adaptability to market demands. The company’s revenue is supported through strategic partnerships that widen its distribution channels in the healthcare sector.AMPLIMED CORPORATION went out of business.

## Funding rounds

- Series D, Mar 3, 2010, $1.5M — Valley Ventures, Solstice Capital
- Series D, Dec 24, 2009, $2M — Solstice Capital
- Series D, Aug 31, 2009, $3.7M — Valley Ventures, Village Ventures, Solstice Capital, InvestBio Ventures, Biotech Insight Ventures
- Series C, Dec 24, 2007, $5M — Valley Ventures, BioMed Partners, Solstice Capital, Biotech Insight Ventures
- Series B, Nov 28, 2006, $8.5M — Valley Ventures, Solstice Capital, InvestBio Ventures, Biotech Insight Ventures
- Series B, Jun 21, 2005, $5M — Valley Ventures, Solstice Capital, InvestBio Ventures, Biotech Insight Ventures
- Series A, Sep 16, 2003, $5M — Valley Ventures, Solstice Capital, InvestBio Ventures, Biotech Insight Ventures

## Investors

- Valley Ventures (https://capitalatlas.ai/funds/valley-ventures) — Series A, Series B, Series C, Series D
- Solstice Capital (https://capitalatlas.ai/funds/solstice-capital) — Series A, Series B, Series C, Series D
- InvestBio Ventures — Series A, Series B, Series D
- Biotech Insight Ventures — Series A, Series B, Series C, Series D
- BioMed Partners (https://capitalatlas.ai/funds/biomed-partners) — Series C
- Village Ventures (https://capitalatlas.ai/funds/village-ventures) — Series D